News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
333,608 Results
Type
Article (15577)
Company Profile (110)
Press Release (317921)
Section
Business (100184)
Career Advice (467)
Deals (18736)
Drug Delivery (48)
Drug Development (33958)
Employer Resources (57)
FDA (8758)
Job Trends (8345)
News (164496)
Policy (14549)
Tag
Academia (1342)
Alliances (28759)
Alzheimer's disease (656)
Approvals (8782)
Artificial intelligence (97)
Bankruptcy (96)
Best Places to Work (6909)
Biotechnology (61)
Breast cancer (105)
Cancer (755)
Cardiovascular disease (67)
Career advice (417)
Cell therapy (134)
Clinical research (28043)
Collaboration (359)
Compensation (104)
COVID-19 (1548)
C-suite (73)
Data (823)
Diabetes (83)
Diagnostics (4668)
Earnings (33084)
Events (50958)
Executive appointments (266)
FDA (9151)
Funding (223)
Gene therapy (95)
GLP-1 (313)
Government (1939)
Healthcare (9246)
Infectious disease (1613)
Inflammatory bowel disease (63)
Interviews (56)
IPO (8123)
Job creations (1774)
Job search strategy (391)
Layoffs (160)
Legal (2633)
Lung cancer (134)
Lymphoma (52)
Manufacturing (149)
Medical device (7304)
Medtech (7308)
Mergers & acquisitions (10795)
Metabolic disorders (222)
Neuroscience (793)
NextGen Class of 2024 (2453)
Non-profit (2119)
Northern California (877)
Obesity (124)
Opinion (56)
People (32010)
Phase I (7090)
Phase II (11222)
Phase III (11748)
Pipeline (312)
Postmarket research (1192)
Preclinical (2645)
Press Release (61)
Radiopharmaceuticals (150)
Rare diseases (107)
Real estate (3915)
Regulatory (10766)
Research institute (1399)
Resumes & cover letters (53)
Southern California (748)
Startups (1601)
United States (7988)
Vaccines (327)
Weight loss (73)
Date
Today (2)
Last 7 days (338)
Last 30 days (1276)
Last 365 days (19849)
2024 (19754)
2023 (22244)
2022 (31702)
2021 (34042)
2020 (32297)
2019 (23998)
2018 (18234)
2017 (16983)
2016 (16242)
2015 (18474)
2014 (13726)
2013 (11209)
2012 (12132)
2011 (11818)
2010 (10393)
Location
Africa (373)
Arizona (66)
Asia (24421)
Australia (4004)
California (1947)
Canada (745)
China (245)
Colorado (80)
Connecticut (81)
Delaware (55)
Europe (51961)
Florida (270)
Georgia (73)
Illinois (169)
Indiana (167)
Japan (70)
Maryland (284)
Massachusetts (1511)
Michigan (132)
Minnesota (151)
New Jersey (720)
New York (609)
North Carolina (435)
Northern California (877)
Ohio (97)
Pennsylvania (479)
South America (564)
Southern California (748)
Texas (261)
Washington State (199)
333,608 Results for "acm global laboratories".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Actimed Therapeutics Announces Publication of Successful S-pindolol benzoate (ACM-001.1) Phase 1 Study in The Journal of Cachexia, Sarcopenia and Muscle
December 13, 2024
·
3 min read
Press Releases
Open-Label Extension Data Confirms Sustained Benefit of Acoramidis on Cardiovascular Outcomes, Including Statistically Significant Reduction in ACM Within 36 Months
November 19, 2024
·
8 min read
Press Releases
Actimed Therapeutics Announces US FDA Grant of Orphan Drug Designation to S-oxprenolol (ACM-002) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
September 4, 2024
·
3 min read
Drug Development
ACM Biolabs Announces Positive Topline Results from a Phase I Trial of SARS-CoV-2 Booster Vaccine ACM-001
ACM Biolabs, a biotechnology company using its next-generation polymer-based delivery platform to develop new nano formulations for use in multiple therapeutic fields, announced positive topline results from a Phase I trial of ACM-001, the Company’s first clinical-stage development program.
September 5, 2023
·
4 min read
Genetown
Charles River Laboratories Achieves 100% Renewable Electricity Usage Globally
Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quarter of 2024, significantly ahead of the original target date.
April 22, 2024
·
4 min read
Press Releases
Frontage Laboratories and Medicover Integrated Clinical Services Announce Strategic Collaboration to Expand Global Genomic Testing Services
November 13, 2024
·
2 min read
Bio NC
Labcorp Launches Global Trial Connect to Accelerate Clinical Trials
Labcorp announced today the launch of Labcorp Global Trial Connect, a suite of central laboratory solutions aimed at increasing the speed of clinical trials where the heart of clinical research is conducted – investigator sites.
June 17, 2024
·
2 min read
Business
ACM Biolabs Further Strengthens Leadership, Appoints David Lawrence to Board of Directors
ACM Biolabs announces the appointment of David Lawrence as Non-Executive Director.
April 11, 2023
·
3 min read
BioCapital
QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development
QPS, a leading global contract research organization (CRO), is pleased to announce new laboratory services capabilities
June 26, 2024
·
4 min read
Press Releases
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference
November 8, 2024
·
5 min read
1 of 33,361
Next
